Health Discovery Corporation

Our Mission Leverage Health Discovery’s intellectual property and clinical partnerships as the world technology leader in biomarker discovery and the science of pharmacogenomics to develop drugs that promise maximum therapeutic benefits with minimal risks for each individual patient. Our Vision Our vision is to reshape the delivery of medicine in order to redefine the relationship between diagnostics, therapeutics and treatment by delivering personalized medicine that incorporates patient-specific information from gene expression, proteomics, metabolic indicators and therapeutic response. Market Opportunity The Food and Drug Administration (FDA), following its initiative in 1987 to expedite approval for new drugs, is encouraging biomarker discovery as key to early detection diagnostics and avoiding newdrug failures in late stage trials. In July 2004, Health Discovery bought the rights to use a patent portfolio of machine learning tools to identify key biomarkers in diagnostics and drug discovery. In May, the Company acquired complete control over the portfolio, comprising over 70 patents and giving Health Discovery ownership of additional patents that are the basis for initiating licensing arrangements and partnerships with numerous businesses unrelated to drug discovery.

Contact Details: 5501 1/2 Abercorn St Savannah GA 31405 United States of America Tel: 912.352.7488 Fax: 800.493.7712 Email: info@healthdiscoverycorp.com WWW: www.healthdiscoverycorp.com/

Loading...

Recent Publications by Health Discovery Corporation:
Fractal genomics modeling: a new approach to genomic analysis and biomarker discovery. Reverse engineering of genetics networks generally requires establishing...	18th July, 2006	Health Discovery Corporation, Inc., Savannah, GA 31406, USA.	Proc IEEE Comput Syst Bioinform Conf. 2004;:9-18.
Optical micturition interval monitor for experimental animals. INTRODUCTION: In the past several years, overactive bladder and urinary...	9th July, 2004	Woman's Health Discovery Research, Urologic Disorders, Wyeth	J Pharmacol Toxicol Methods. 2002 Nov-Dec;48(3):147-52. DOI Direct Link
Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Atherosclerosis is a chronic inflammatory disease that develops in...	14th January, 2004	Cardiovascular-Women's Health Discovery Research, Wyeth Research,	Am J Transplant. 2003 May;3(5):562-9.
Functional annotation of the putative orphan Caenorhabditis elegans G-protein-coupled receptor C10C6.2 as a FLP15 peptide receptor. This report describes the cloning and functional annotation of a...	6th January, 2004	Animal Health Discovery Research, Pharmacia Corporation, Kalamazoo, MI	J Biol Chem. 2003 Oct 24;278(43):42115-20. Epub 2003 Aug 22. DOI Direct Link
Differential activation of "social" and "solitary" variants of the Caenorhabditis elegans G protein-coupled receptor NPR-1 by its cognate ligand AF9. Natural variations of wild Caenorhabditis elegans isolates having either...	8th October, 2003	Animal Health Discovery Research, Pharmacia Corp., Kalamazoo, Michigan	J Biol Chem. 2003 Sep 5;278(36):33724-9. Epub 2003 Jun 23. DOI Direct Link
→View more Health Discovery Corporation research publications.

BioNews Results for Health Discovery Corporation:
Molecular Mechanisms of Neovascularization in AMD	Retinal Physician:  Jul 19 2008 8:38PM Matching: health discovery
New Initiative Unleashes the Power of Paws(TM)	Genetic Engineering News:  Jul 16 2008 2:53PM Matching: health discovery
Research and Markets: Latest Most Up-to-Date Cancer Personalized Medicine Market Report	TMC Net:  Jul 16 2008 12:51PM Matching: health discovery
Latest Most Up-to-Date Cancer Personalized Medicine Market Report	SmartBrief:  Jul 16 2008 9:01AM Matching: health discovery
Latest Most Up-to-Date Cancer Personalized Medicine Market Report	Houston Chronicle:  Jul 16 2008 8:31AM Matching: health discovery
Promote your company here: BioNewsCast - Press Release Distribution	→View more Health Discovery Corporation news.

Health Discovery Corporation Patents:
US Patent No.	Title
7383237	Computer-aided image analysis
7366719	Method for the manipulation, storage, modeling, visualization and quantification of datasets
7353215	Kernels and methods for selecting kernels for use in learning machines
7318051	Methods for feature selection in a learning machine
7299213	Method of using kernel alignment to extract significant features from a large dataset
→View more Health Discovery Corporation patents.

Health Discovery Corporation (HDVY.OB) Financial information Links from Barchart
HDVY.OB Quote from from Barchart.com
HDVY.OB Chart from from Barchart.com
HDVY.OB Profile from from Barchart.com
HDVY.OB Opinion from from Barchart.com
→View more Health Discovery Corporation finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 273 times since April 2007, the link to the organisation's website has been followed 67 times

Recent Search Terms used to find this page: what are the health discoveries in 2008 | Health Discovery Corp. | Patent No. 7 353 215 | healthcare discovery corporation | .

Search for more companies in Savannah

Search for more companies in GA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Health Discovery Corporation